Literature DB >> 15750083

Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.

A Deplano1, O Denis, L Poirel, D Hocquet, C Nonhoff, B Byl, P Nordmann, J L Vincent, M J Struelens.   

Abstract

We describe the molecular characterization of a multiresistant Pseudomonas aeruginosa clone causing an outbreak in the intensive care unit (ICU) of a tertiary-care university hospital. Analysis included antimicrobial susceptibility profile, O-serotyping, pulsed-field gel electrophoresis, and amplified fragment length polymorphism. Resistance mechanisms were characterized, including production of naturally occurring and acquired beta-lactamases, porin expression, and efflux pump systems. Eighteen patients were colonized or infected with multiresistant P. aeruginosa. Multiresistant P. aeruginosa was panresistant to penicillins, cephalosporins, carbapenems, aminoglycosides, and fluoroquinolones and remained susceptible only to colistin. Sixteen isolates (89%) belonged to serotype O:11, pulsed-field gel electrophoresis type A1, and amplified fragment length polymorphism type A. Resistance characterization of this epidemic clone showed an overexpression of the chromosomal cephalosporinase AmpC combined with decreased expression of porin OprD and the absence of metallo-beta-lactamase or extended-spectrum beta-lactamase. An upregulation of the MexXY efflux system due to an agrZ mutation in the mexZ repressor was detected. This epidemic clone was restricted to the ICU and was not found elsewhere in hospital. Contamination of the ICU environment and the hands of an ICU nurse with this clone suggests possible hand-borne transmission. Implementation of contact precautions effectively controlled transmission of the epidemic clone. This study illustrates the ability of multiresistant P. aeruginosa to cause an outbreak with significant morbidity and mortality and underscores the need to identify clonal outbreaks, which require targeted infection control measures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750083      PMCID: PMC1081292          DOI: 10.1128/JCM.43.3.1198-1204.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa.

Authors:  D Talon; V Cailleaux; M Thouverez; Y Michel-Briand
Journal:  J Hosp Infect       Date:  1996-02       Impact factor: 3.926

2.  Microbial resistance: lessons from the EPIC study. European Prevalence of Infection.

Authors:  J L Vincent
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

3.  Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group.

Authors:  P T Tassios; V Gennimata; A N Maniatis; C Fock; N J Legakis
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

5.  Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit.

Authors:  H Speijer; P H Savelkoul; M J Bonten; E E Stobberingh; J H Tjhie
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?

Authors:  R L Moolenaar; J M Crutcher; V H San Joaquin; L V Sewell; L C Hutwagner; L A Carson; D A Robison; L M Smithee; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  2000-02       Impact factor: 3.254

7.  Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis.

Authors:  M J Struelens; F Rost; A Deplano; A Maas; V Schwam; E Serruys; M Cremer
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

8.  Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen.

Authors:  H Grundmann; A Kropec; D Hartung; R Berner; F Daschner
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

9.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

10.  Carbapenem-hydrolyzing metallo-beta-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France.

Authors:  L Poirel; L Collet; P Nordmann
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

View more
  47 in total

1.  Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia.

Authors:  Matthew E Falagas; Patra K Koletsi; Petros Kopterides; Argyris Michalopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

3.  Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.

Authors:  Xavier Mulet; Gabriel Cabot; Alain A Ocampo-Sosa; M Angeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

4.  Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens.

Authors:  Ariane Deplano; Olivier Denis; Hector Rodriguez-Villalobos; Raf De Ryck; Marc J Struelens; Marie Hallin
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

5.  Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.

Authors:  Esther Viedma; Carlos Juan; Joshi Acosta; Laura Zamorano; Joaquín R Otero; Francisca Sanz; Fernando Chaves; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

Review 6.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 7.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

8.  Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.

Authors:  Muhammad-Hariri Mustafa; Hussein Chalhoub; Olivier Denis; Ariane Deplano; Anne Vergison; Hector Rodriguez-Villalobos; Michael M Tunney; J Stuart Elborn; Barbara C Kahl; Hamidou Traore; Francis Vanderbist; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.

Authors:  Bartolome Moya; Laura Zamorano; Carlos Juan; José L Pérez; Yigong Ge; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.